This has been a tricky one to nail down because it depends upon not only revenue, but product mix as well. Let me take another stab at it though:
For this quarter, Q416, the estimate is around $41.1M at an eps loss of $0.03 per share. There are 83.54M shares outstanding, so that is a loss of $2.5M. If we add that back in, we get a BE of $43.6M.
For next quarter, Q117, the estimate is $43.1M with a $0.01 loss per share. So that loss is $0.84M. Adding the loss back in we get a BE of $43.9M.
For the year, revenue is projected to be around $159.39M with a loss of $0.12 per share. The loss would be around $10M for the year. Adding that back in I get $169.4M. Dividing that by 4 yields a BE of $42.3M.
Taking the average...
$43.3M
AMCC could come very close to hitting BE by Q117 (the June quarter). Given that the March and June quarters seem to be the quarters that are seasonal for showing positive earnings surprises, this could have significant implications for the share valuation.
Perhaps this is why valuations have been trending upward recently (?)